• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Health IT, Digital Health Interviews | Q/A - HIT Consultant

Q/A: IQVIA’s Global Lead Talks Unlocking AI for Drug Repurposing

by Fred Pennic 05/23/2023 Leave a Comment

In an interview with HIT Consultant, Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA talks how unlocking artificial intelligence (AI) in drug repurposing is transforming pharma and biotech companies. What are some of the challenges and problems associated with drug discovery “from scratch”?  Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA: In the traditional drug discovery and development paradigm, it can cost up to $1.8 billion and
Read More

Q/A: CalmWave CEO Talks Leveraging AI to Reduce Alarm Fatigue

by Syed Hamza Sohail 05/08/2023 Leave a Comment

CalmWave, Inc.: Leveraging AI Technologies to Reduce Alarm Fatigue

What You Should Know: Healthcare providers face the difficult challenge of coping with an ever-increasing workload while still providing high-quality patient care and trying to retain their staff. As the CEO of CalmWave, Inc., Ophir Ronen is an expert in both patient outcomes and staff retention who understands the importance of leveraging AI technologies to reduce alarm fatigue and deliver more efficient quiet care.  Delivering Efficient Care by Reducing Alarm Fatigue Alarm fatigue is
Read More

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

by Syed Hamza Sohail 03/22/2023 Leave a Comment

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

What You Should Know: - A recent study published in JAMA found that conventional genomic tests commonly used for breast cancer tumors can be less accurate for Black women. This news comes at a time when Black women with breast cancer are experiencing mortality rates that are 41% higher than white women. - Dr. Nathalie Johnson, MD FACS and President of The American Society of Breast Cancer Surgeons is among numerous doctors who advocate for Agendia and its tests which look beyond race,
Read More

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

by Fred Pennic 03/13/2023 Leave a Comment

Dr. Arti Masturzo

Today, food insecurity affects more than 41 million Americans and is prevalent among children and the elderly population. Food insecurity is defined as the limited availability of nutritionally adequate and safe food or the inability to acquire these foods in socially acceptable ways. As a result, food insecurity can exacerbate medical conditions driving up hospital/health systems patient care costs. To learn more about how healthcare providers can address food insecurity, we sat down with Dr.
Read More

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

by Fred Pennic 02/16/2023 Leave a Comment

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Today, cancer is the second leading cause of death in the United States. Sadly, cancer disparities exist, with racial/ethnic minority, low-income, and uninsured populations suffering the greatest burden. That’s why routine cancer screening is critical to addressing cancer disparities as they have the potential to greatly reduce both incidence and mortality rates. To address this, Federally qualified health centers (FQHCs) are funded by the Health Resources and Services Administration to provide
Read More

Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations

by Fred Pennic 12/20/2022 Leave a Comment

Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations

Diabetes prevention is one of the biggest challenges in the healthcare industry as more than 37 million Americans (11.3% of the population) suffer from this debilitating chronic disease. As we close the year out, we sat down with Jon Bloom, MD, CEO and Co-founder of diabetic healthcare tech company Podimetrics to learn how the industry and his company are working to implement health equity change to serve patients living with advanced diabetes. The company’s FDA-cleared SmartMat provides a
Read More

ConcertAI CEO Talks COVID-19  & The De-Risking of Technology to Keep Trials Moving

by Fred Pennic 11/09/2022 Leave a Comment

ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving

Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More

DeliverHealth Exec Talks Combatting Physician Burnout with Automation Tech & Data

by Fred Pennic 08/29/2022 Leave a Comment

DeliverHealth Exec Talks Combatting Physician Burnout with Automation Tech & Data

Provider burnout has shown no signs of slowing down in the past couple of years - a fact proven by a recent report found that 45% of physicians have been experiencing burnout over the past two years.  As providers and healthcare organizations continue to face burnout, staffing shortages and financial pressures, they must find a way to reduce administrative burdens while allowing for more time spent on patient care with an ultimate end goal of reducing burnout. We recently spoke with
Read More

How Continuous Optimization of Marketing Outcomes Improves Brand Performance and Patient Outcomes – Q/A

by Fred Pennic 10/22/2021 Leave a Comment

Continuous Optimization of Marketing Outcomes Improves Brand Performance and Patient Outcomes

As fall turns to winter, pharmaceutical brand marketers and supporting teams know one thing is certain: next year’s planning cycle is upon us in earnest. With data-driven decision-making at the core of best practices, and an increasing fluency in tying aggregated, non-identified prescription data to a brand’s efforts, the evidence continues to support the Continuous Optimization approach to driving patient outcomes. The results demonstrate that not only we can improve brand performance, but also
Read More

First Databank Clinician Addresses COVID-19 Vaccine Skepticism – Q/A

by Fred Pennic 03/03/2021

As the Biden administration ramps up its efforts to increase the access of COVID-19 vaccines to more Americans, there are a large number of Americans who are skeptical about of the COVID-19 vaccine. About 1 in 3 Americans stated they definitely or probably won’t get the COVID-19 vaccine, according to a recent poll from the Associated Press-NORC Center for Public Affairs Research. The poll reveals while 67% of Americans plan to get vaccinated or have already done so, 15% are certain they
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 13
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |